dphongthai, This is from Baillieu https://www.baillieuholst.com.au/publishedresearch/2018/The Prospector_VEC_27Jul18.pdf Cheers
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%